These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 5217487)
1. Report of the Committee on Biologics. Proc Annu Meet U S Anim Health Assoc; 1964; 68():100-1. PubMed ID: 5217487 [No Abstract] [Full Text] [Related]
2. Requirements for experimental biologics and biological products distributed under special license. Peacock GV Proc Annu Meet U S Anim Health Assoc; 1964; 68():96-9. PubMed ID: 5217548 [No Abstract] [Full Text] [Related]
3. Carrying out the responsibility to industry relative to animal biologics. Hejl JM Proc Annu Meet U S Anim Health Assoc; 1967; 71():50-60. PubMed ID: 5257329 [No Abstract] [Full Text] [Related]
4. The Unites States Department of Agriculture Regulation of Veterinary Biological Products. The use of prelicensing evaluation and postlicensing monitoring to achieve regulatory compliance. Hill RE; Randall DC Qual Assur; 1995 Dec; 4(4):323-8. PubMed ID: 8890360 [TBL] [Abstract][Full Text] [Related]
5. Regulation of autogenous biologicals in the United States. Schmellik-Sandage CS; Hill RE Dev Biol (Basel); 2004; 117():9-13. PubMed ID: 15597610 [TBL] [Abstract][Full Text] [Related]
7. Problems and progress in biological products control. Hejl JM J Am Vet Med Assoc; 1968 Dec; 153(12):1803-8. PubMed ID: 5725849 [No Abstract] [Full Text] [Related]
9. [The production of veterinary preparations and control of their quality]. Deshkevich DK Veterinariia; 1968 Jul; 45(7):61-2. PubMed ID: 5736461 [No Abstract] [Full Text] [Related]
10. [Biological industry on the rise]. Zviagin IV Veterinariia; 1970; 46(4):21-4. PubMed ID: 5459440 [No Abstract] [Full Text] [Related]
11. Conditional licensing of veterinary biologicals in the United States: a major manufacturer's perspective. Carlson MM; Chiang YW; Chu HJ Dev Biol (Basel); 2004; 117():97-103. PubMed ID: 15597624 [No Abstract] [Full Text] [Related]
12. [The use of tissue preparations]. Semak IL; Mosolov NI; Daludin FI Veterinariia; 1969 Jun; 46(6):62-3. PubMed ID: 5392286 [No Abstract] [Full Text] [Related]
13. Opportunities and expectations. Espeseth DA Dev Biol (Basel); 2004; 117():3-6. PubMed ID: 15597609 [No Abstract] [Full Text] [Related]
15. [The composition and biological properties of an agar-tissue preparation]. Makarov MA; Lebedev VA Veterinariia; 1966 Dec; 43(12):49-50. PubMed ID: 6000549 [No Abstract] [Full Text] [Related]
16. Early veterinary biologics. Niemi SM Mod Vet Pract; 1980 Nov; 61(11):926-9. PubMed ID: 7007863 [No Abstract] [Full Text] [Related]
17. The market for follow-on biologics: how will it evolve? Grabowski H; Cockburn I; Long G Health Aff (Millwood); 2006; 25(5):1291-301. PubMed ID: 16966725 [TBL] [Abstract][Full Text] [Related]
18. WHO Expert Committee on Biological Standardization. World Health Organization World Health Organ Tech Rep Ser; 2006; 932():v-vi, 1-137. PubMed ID: 17274191 [TBL] [Abstract][Full Text] [Related]
19. International symposium on fish biologics: serodiagnosis and vaccines. Preparation of biologics: technical aspects. Dev Biol Stand; 1981; 49():207-64. PubMed ID: 7308582 [No Abstract] [Full Text] [Related]
20. The practitioner's role in evaluating veterinary biologics. Jones RP J Am Vet Med Assoc; 1970 Sep; 157(6):817-9. PubMed ID: 5469727 [No Abstract] [Full Text] [Related] [Next] [New Search]